Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2022 R33 CA21-004 LANDAU, DAN WEILL MEDICAL COLL OF CORNELL UNIV Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes Active
2020 R44 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues Active
2019 R33 RFA-CA-18-003 YANG, JENNY J. GEORGIA STATE UNIVERSITY Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment Active
2018 R33 RFA-CA-17-013 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity Active
2022 R33 CA21-004 WANG, TZA-HUEI JEFF JOHNS HOPKINS UNIVERSITY A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies Active
2020 R43 PAR-18-303 REDER, NICHOLAS LIGHTSPEED MICROSCOPY, INC. Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies Active
2019 R33 RFA-CA-18-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia Active
2022 R33 CA21-004 NAEGLE, KRISTEN M UNIVERSITY OF VIRGINIA A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptides Active
2020 R21 RFA-CA-19-019 SHVETS, GENNADY CORNELL UNIVERSITY Phenotypic Assay For Drug Discovery And Personalized Medicine Based On Real-time Vibrational Spectroscopy Enhanced By Plasmonic Metasurfaces Active
2019 R33 RFA-CA-18-003 BREUNIG, JOSHUA JOHN CEDARS-SINAI MEDICAL CENTER GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models Active
2018 R43 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues Active
2022 R21 CA21-003 KELLY, RYAN T BRIGHAM YOUNG UNIVERSITY In-depth and label-free proteome profiling of hundreds of single cells per day Active
2020 R21 RFA-CA-19-019 TEWARI, MUNEESH UNIVERSITY OF MICHIGAN AT ANN ARBOR Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers Active
2019 R33 RFA-CA-18-003 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES Optimization and validation of integrated microscale technologies for low-cost; automated production of PET molecular imaging tracers for cancer research Active
2022 R21 CA21-005 TANG, SINDY KAM-YAN STANFORD UNIVERSITY A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy Active
2020 R33 RFA-CA-19-020 WANG, SIYUAN YALE UNIVERSITY Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer Active
2019 R21 RFA-CA-18-004 SINGAMANENI, SRIKANTH WASHINGTON UNIVERSITY METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION Active
2022 R21 CA21-003 KNOWLES, DAVID ARTHUR NEW YORK GENOME CENTER A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer Active
1999 R43 PAR-98-066 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2002 R21 PAR-01-104 LARSON, DALE N HARVARD UNIVERSITY (MEDICAL SCHOOL) PROTEIN LOCALIZATION: MULTI-APERTURE NEAR-FIELD OPTICS Complete
2005 R21 RFA-CA-05-002 GUDKOV, ANDREI V CLEVELAND CLINIC LERNER COL/MED-CWRU ISSA: NOVEL FUNCTIONAL APPROACH TO CANCER-RELATED GENES Complete
2008 R21 RFA-CA-07-033 LANDEGREN, ULF DAG UPPSALA UNIVERSITY DIAGNOSTIC ANALYSES OF ENDOGENOUS PROTEIN INTERACTIONS Complete
2011 R21 RFA-CA-10-001 HAGEDORN, CURT H. UNIVERSITY OF UTAH SENTINEL POL II RNAS FOR MEASURING RNA INTEGRITY IN BIOSPECIMENS Complete
2015 R21 RFA-CA-14-003 MACCOSS, MICHAEL UNIVERSITY OF WASHINGTON SYSTEMATIC AND COMPREHENSIVE SAMPLING OF PEPTIDES IN MIXTURES BY TANDEM MASS SPECTROMETRY Complete
2021 R21 CA20-017 HAINER, SARAH JANE UNIVERSITY OF PITTSBURGH AT PITTSBURGH Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN Complete
1999 R21 PAR-98-067 BASEDOW, ROBERT W RAYTHEON SYSTEMS COMPANY HYPERSPECTRAL SYSTEM FOR MOLECULAR ANALYSIS OF CANCER Complete
2001 R33 PAR-99-100 MALKHOSYAN, SERGEI R BURNHAM INSTITUTE FOR MEDICAL RESEARCH COMPARATIVE HYBRIDIZATION OF AP PCR ARRAYS Complete
2003 R44 PAR-99-101 GAO, JUN CALIBRANT BIOSYSTEMS, INC. ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS Complete
2007 R21 RFA-CA-07-003 ROGERS, RICK HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) SAMPLE PREP METHODS TO ALLOW AUTOMATED 3D ANALYSIS OF MICROVESSEL MORPHOLOGY Complete
2010 R21 RFA-CA-09-004 POPESCU, GABRIEL UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN LABEL FREE IMAGING OF BLOOD SMEARS AND TISSUE BIOPSIES Complete
2013 R44 RFA-CA-08-011 DUFFY, DAVID C QUANTERIX CORPORATION SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS Complete
2000 R43 PAR-99-101 CHO, RAYMOND JAIHYUN INGENUITY SYSTEMS, INC. FUNCTIONAL CLUSTERING APPROACH TO GENOMIC ANALYSIS Complete
2002 R44 PAR-99-101 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. LIGHT-UP PNA ARRAYS Complete
2006 R33 RFA-CA-06-002 BRENT, ROGER VTT/MSI MOLECULAR SCIENCES INSTITUTE TADPOLE ASSAYS FOR THE MOLECULAR ASSESSMENT OF CANCER Complete
2009 R21 RFA-CA-08-006 BURBULIS, IAN E VTT/MSI MOLECULAR SCIENCES INSTITUTE PCR FOR CARBOHYDRATE CANCER BIOMARKERS Complete
2013 R21 RFA-CA-12-002 PAN, TINGRUI UNIVERSITY OF CALIFORNIA AT DAVIS DIGITAL ONE-DISC-ONE-COMPOUND ARRAY FOR HIGH-THROUGHPUT DISCOVERY OF CANCER-TARGE Complete
2016 R33 RFA-CA-15-003 GARRAWAY, LEVI A BROAD INSTITUTE, INC. CLINICAL IMPLEMENTATION OF SINGLE CELL TUMOR TRANSCRIPTOME ANALYSIS Complete
2000 R21 PAR-99-102 PALLAVICINI, MARIA G. UNIVERSITY OF CALIFORNIA SAN FRANCISCO PROTEIN SIGNATURES OF LEUKEMIC CELLS Complete
2002 R33 PAR-99-100 ISSA, JEAN-PIERRE J UNIVERSITY OF TEXAS MD ANDERSON CAN CTR NEOPLASIA AND METHYLATED CPG ISLANDS AMPLIFICATION Complete
2005 R33 RFA-CA-05-003 D'ERRICO, FRANCESCO YALE UNIVERSITY CHEMOTHERAPY WITH INJECTABLE MICRODROPLETS Complete
2008 R33 RFA-CA-07-036 VIDAL, MARC DANA-FARBER CANCER INST APPLICATION OF TECHNOLOGIES FOR INTERACTOME NETWORK ANALYSES OF CANCER MUTATIONS Complete
2011 R33 RFA-CA-10-004 JU, JINGFANG STATE UNIVERSITY NEW YORK STONY BROOK IDENTIFICATION OF POST-TRANSCRIPTIONALLY REGULATED TARGETS BY TRIP-CHIP/SEQ Complete
2015 R33 RFA-CA-14-004 SCHWARTZ, DAVID C. UNIVERSITY OF WISCONSIN-MADISON SCALABLE CANCER GENOMICS VIA NANOCODING AND SEQUENCING Complete
2019 R43 PAR-18-303 KHODAVERDIAN, VARANDT Y. NUPROBE USA, INC. Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing Complete
1999 R43 PAR-98-066 CHEE, MARK S. ILLUMINA, INC. PARALLEL ARRAY PROCESSOR Complete
2002 R21 PAR-01-104 VIDAL, MARC DANA-FARBER CANCER INSTITUTE A C. ELEGANS LOCALIZATION-OF-EXPRESSION MAPPING PROJECT Complete
2005 R21 RFA-CA-05-002 POOLE, LESLIE B WAKE FOREST UNIVERSITY HEALTH SCIENCES PROFILING OF REDOX-SENSITIVE SIGNALING PROTEINS Complete
2008 R21 RFA-CA-07-033 WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY NANOBIOSENSING METHOD FOR POINT MUTATION DETECTION OF CANCER Complete
2011 R21 RFA-CA-10-001 GULLEY, MARGARET L UNIV OF NORTH CAROLINA CHAPEL HILL ENHANCED FORMALIN FIXATION TO IMPROVE TESTS ON SOLID TISSUES Complete
2015 R21 RFA-CA-14-003 IAFRATE, ANTHONY JOHN MASSACHUSETTS GENERAL HOSPITAL HIGHLY MULTIPLEXED FISH FOR IN SITU GENOMICS Complete

Pages